{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:48:37Z","timestamp":1774896517719,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omtm.2025.101476","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T11:15:23Z","timestamp":1745061323000},"page":"101476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Harnessing synaptic vesicle release and recycling with antibody shuttle for targeted delivery of therapeutics to neurons"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0685-6729","authenticated-orcid":false,"given":"Karen Kar Lye","family":"Yee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Kumamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daijiro","family":"Inomata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuhei","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5947-495X","authenticated-orcid":false,"given":"Norihiro","family":"Yumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101476_bib1","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.7150\/thno.21254","article-title":"Current Strategies for Brain Drug Delivery","volume":"8","author":"Dong","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.omtm.2025.101476_bib2","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/bph.15802","article-title":"Altered blood-brain barrier and blood-spinal cord barrier dynamics in amyotrophic lateral sclerosis: Impact on medication efficacy and safety","volume":"179","author":"Yijun","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.omtm.2025.101476_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtm.2025.101476_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.22421","article-title":"The blood-spinal cord barrier: morphology and clinical implications","volume":"70","author":"Viktor","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2025.101476_bib5","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","article-title":"Modern methods for delivery of drugs across the blood-brain barrier","volume":"64","author":"Chen","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtm.2025.101476_bib6","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"William","year":"2012","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.omtm.2025.101476_bib7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1248\/cpb.c19-00854","article-title":"Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood\u2013Brain Barrier Using Receptor-Mediated Transcytosis","volume":"68","author":"Toshihiko","year":"2020","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.omtm.2025.101476_bib8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/biomedicines12040851","article-title":"Transcytosis-Driven Treatment of Neurodegenerative Disorders by mRNA-Expressed Antibody\u2013Transferrin Conjugates","volume":"12","author":"Sarfaraz","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.omtm.2025.101476_bib9","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuron.2019.02.017","article-title":"Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality","volume":"101","author":"Eloise","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2025.101476_bib10","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1021\/acs.molpharmaceut.3c01167","article-title":"Cell-Penetrating Peptides: Promising Therapeutics and Drug-Delivery Systems for Neurodegenerative Diseases","volume":"21","author":"Mitra","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omtm.2025.101476_bib11","article-title":"Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma","volume":"7","author":"Kasper","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101476_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2013.10.061","article-title":"Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle","volume":"81","author":"Jens","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2025.101476_bib13","article-title":"Enhanced in vivo blood brain barrier transcytosis of macromolecular cargo using an engineered pH-sensitive mouse transferrin receptor binding nanobody","volume":"20","author":"Thomas","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.omtm.2025.101476_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12987-020-00209-0","article-title":"Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human","volume":"17","author":"Wandong","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.omtm.2025.101476_bib15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2015.12.013","article-title":"Targeting specific cells in the brain with nanomedicines for CNS therapies","volume":"240","author":"Fan","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.omtm.2025.101476_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4161\/mabs.22854","article-title":"Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates","volume":"5","author":"Michael","year":"2013","journal-title":"mAbs"},{"key":"10.1016\/j.omtm.2025.101476_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-241786","article-title":"Complications associated with intrathecal drug delivery in a paediatric patient with Niemann-Pick type C","volume":"14","author":"Rodriguez Ciancio","year":"2021","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.omtm.2025.101476_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1517\/17425240903540205","article-title":"Central nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics","volume":"7","author":"Ryan","year":"2010","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.omtm.2025.101476_bib19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature11348","article-title":"Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses","volume":"489","author":"Norihiro","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101476_bib20","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.neuron.2009.12.019","article-title":"LRRTM2 interacts with Neurexin1 and regulates excitatory synapse formation","volume":"64","author":"Joris","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2025.101476_bib21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.neuron.2009.12.012","article-title":"LRRTM2 functions as a neurexin ligand in promoting excitatory synapse formation","volume":"64","author":"Jaewon","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2025.101476_bib22","first-page":"E5382","article-title":"Deletion of LRRTM1 and LRRTM2 in adult mice impairs basal AMPA receptor transmission and LTP in hippocampal CA1 pyramidal neurons","volume":"115","author":"Mehdi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101476_bib23","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1471-4159.2010.07141.x","article-title":"Neurexins, neuroligins and LRRTMs: synaptic adhesion getting fishy","volume":"117","author":"Gavin","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.omtm.2025.101476_bib24","article-title":"Distinct but overlapping roles of LRRTM1 and LRRTM2 in developing and mature hippocampal circuits","volume":"11","author":"Shreya","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.omtm.2025.101476_bib25","article-title":"Generation of Antibodies to Difficult Membrane Protein Targets","author":"Joshua","year":"2021","journal-title":"Antibody SolutionsScientific Poster"},{"key":"10.1016\/j.omtm.2025.101476_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.toxicon.2022.04.003","article-title":"The distribution of neuromuscular junctions depends on muscle pennation, when botulinum neurotoxin receptors and SNAREs expression are uniform in the rat","volume":"212","author":"Denis","year":"2022","journal-title":"Toxicon"},{"key":"10.1016\/j.omtm.2025.101476_bib27","first-page":"4703","article-title":"Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in Spinal Muscular Atrophy","volume":"25","author":"Roc\u00edo","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101476_bib28","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1073\/pnas.1912012117","article-title":"Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier","volume":"117","author":"Oscar","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101476_bib29","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.3390\/molecules29245997","article-title":"Endosomal Escape and Nuclear Localization: Critical Barriers for Therapeutic Nucleic Acids","volume":"29","author":"Randall","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.omtm.2025.101476_bib30","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1212\/WNL.0000000000002185","article-title":"Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndrome","volume":"85","author":"Roger","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.omtm.2025.101476_bib31","article-title":"New recessive mutations in SYT2 causing severe presynaptic congenital myasthenic syndromes","volume":"6","author":"St\u00e9phanie","year":"2020","journal-title":"Neurol Genet."},{"key":"10.1016\/j.omtm.2025.101476_bib32","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/nature05387","article-title":"Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity","volume":"444","author":"Rongsheng","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101476_bib33","article-title":"Delivery of single-domain antibodies into neurons using a chimeric toxin-based platform is therapeutic in mouse models of botulism","volume":"13","author":"Shin-Ichiro","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2025.101476_bib34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/toxins10050208","article-title":"The Expanding Therapeutic Utility of Botulinum Neurotoxins","volume":"10","author":"Elena","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.omtm.2025.101476_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/pharmaceutics10030083","article-title":"Overview of Antibody Drug Delivery","volume":"10","author":"Sahar","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtm.2025.101476_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"Ruei-Min","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.omtm.2025.101476_bib37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/mabs.20776","article-title":"Molecular engineering of antibodies for therapeutic and diagnostic purposes","volume":"4","author":"Fr\u00e9d\u00e9ric","year":"2012","journal-title":"mAbs"},{"key":"10.1016\/j.omtm.2025.101476_bib38","first-page":"30","article-title":"Acid-Responsive Transferrin Dissociation and GLUT Mediated Exocytosis for Increased Blood\u2013Brain Barrier Transcytosis and Programmed Glioma Targeting Delivery","volume":"28","author":"Shaobo","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.omtm.2025.101476_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20131660","article-title":"Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants","volume":"211","author":"Bien-Ly","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omtm.2025.101476_bib40","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS","volume":"387","author":"Timothy","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtm.2025.101476_bib41","first-page":"53","article-title":"A quantitative way to estimate clinical off-target effects for human membrane brain targets in CNS research and development","volume":"4","author":"Athan","year":"2012","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.omtm.2025.101476_bib42","first-page":"615","article-title":"Current perspectives on intrathecal drug delivery","volume":"7","author":"Michael","year":"2014","journal-title":"J. Pain Res."},{"key":"10.1016\/j.omtm.2025.101476_bib43","doi-asserted-by":"crossref","first-page":"13493","DOI":"10.1523\/JNEUROSCI.3519-06.2006","article-title":"Synaptotagmin-2 is essential for survival and contributes to Ca2+ triggering of neurotransmitter release in central and neuromuscular synapses","volume":"26","author":"Zhiping","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtm.2025.101476_bib44","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/jcbfm.2013.160","article-title":"Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier","volume":"33","author":"Isabelle","year":"2013","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.omtm.2025.101476_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/srep16763","article-title":"High yield extraction of pure spinal motor neurons, astrocytes and microglia from single embryo and adult mouse spinal cord","volume":"5","author":"Beaudet","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101476_bib45","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1021\/acschemneuro.6b00374","article-title":"Neurocytometry: Flow Cytometric Sorting of Specific Neuronal Populations from Human and Rodent Brain","volume":"8","author":"David","year":"2017","journal-title":"ACS Chem. Neurosci."}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T18:51:51Z","timestamp":1759863111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125000713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2329050125000713"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101476","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing synaptic vesicle release and recycling with antibody shuttle for targeted delivery of therapeutics to neurons","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101476"}}